ArticleJournal of applied clinical medical physics2019
Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
Article in Journal of applied clinical medical physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01584258 (International Randomised Study of Prostatectomy vs Stereotactic Body Radiotherapy), which is not on this map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
International Randomised Study of Prostatectomy vs Stereotactic Body Radiotherapy (SBRT) and Conventionally Fractionated Radiotherapy vs SBRT for Organ-Confined Prostate Cancer
Who cites it
21 citing papers in PubMed.
- Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.BMC cancer · 2021Trial
- Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy.The British journal of radiology · 2019Trial
- Comparison of platinum and gold fiducial markers for prostate radiotherapy: a phantom study.Radiological physics and technology · 2026Article
- Clinical indicators for dose re-optimization in magnetic resonance-guided online adaptive radiotherapy for prostate cancer.Physics and imaging in radiation oncology · 2026Article
- Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.Frontiers in oncology · 2024Article
- Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.JAMA oncology · 2023Article
- Optimal planning target margin for prostate radiotherapy based on interfractional and intrafractional variability assessment during 1.5T MRI-guided radiotherapy.Frontiers in oncology · 2023Article
- 1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients.Journal of personalized medicine · 2022Article
- Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?Clinical and translational radiation oncology · 2022Article
- MR-guided radiotherapy for prostate cancer: state of the art and future perspectives.The British journal of radiology · 2022Review
- Minimally invasive magnetic resonance image-guided prostate interventions.The British journal of radiology · 2022Review
- A narrative review of MRI acquisition for MR-guided-radiotherapy in prostate cancer.Quantitative imaging in medicine and surgery · 2022Review
- Urethral Interfractional Geometric and Dosimetric Variations of Prostate Cancer Patients: A Study Using an Onboard MRI.Frontiers in oncology · 2022Article
- Synthetic digital reconstructed radiographs for MR-only robotic stereotactic radiation therapy: A proof of concept.Computers in biology and medicine · 2021Article
- [Primary treatment of prostate cancer using 1.5 T MR-linear accelerator].Der Radiologe · 2021Review
- Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results.Journal of clinical medicine · 2021Article
- Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator.Physics and imaging in radiation oncology · 2021Article
- MR-Guided Adaptive Radiotherapy for Bladder Cancer.Frontiers in oncology · 2021Review
- Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac.Clinical and translational radiation oncology · 2020Article
- MR-Guided Radiotherapy for Prostate Cancer.Frontiers in oncology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
background and purposeIntraprostatic fiducial markers (FM) improve the accuracy of radiotherapy (RT) delivery. Here we assess geometric integrity and contouring consistency using a T2*-weighted (T2*W) sequence alone, which allows visualization of the FM. MATERIAL AND
methodsTen patients scanned within the Prostate Advances in Comparative Evidence (PACE) trial (NCT01584258) had prostate images acquired with computed tomography (CT) and Magnetic Resonance (MR) Imaging: T2-weighted (T2W) and T2*W sequences. The prostate was contoured independently on each imaging dataset by three clinicians. Interobserver variability was assessed using comparison indices with Monaco ADMIRE (research version 2.0, Elekta AB) and examined for statistical differences between imaging sets. CT and MR images of two test objects were acquired to assess geometric distortion and accuracy of marker positioning. The first was a linear test object comprising straight tubes in three orthogonal directions, the second was a smaller test object with markers suspended in gel.
resultsInterobserver variability for prostate contouring was lower for both T2W and T2*W compared to CT, this was statistically significant when comparing CT and T2*W images. All markers are visible in T2*W images with 29/30 correctly identified, only 3/30 are visible in T2W images. Assessment of geometric distortion revealed in-plane displacements were under 0.375 mm in MRI, and through plane displacements could not be detected. The signal loss in the MR images is symmetric in relation to the true marker position shown in CT images.
conclusionProstate T2*W images are geometrically accurate, and yield consistent prostate contours. This single sequence can be used to identify FM and for prostate delineation in a mixed MR-CT workflow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.